Skip to main content
Premium Trial:

Request an Annual Quote

Interleukin Genetics

Premium

Interleukin Genetics has won a patent from the US Patent and Trademark Office for the discovery that “certain common” SNPs in the Interleukin-1 genes are linked to an increased risk for osteoporosis. In a recent study, the company showed that certain SNPs in the IL-1 genes “produce lifelong tendencies to have more inflammation or qualitative differences in inflammation mechanisms. Any one of different IL-1 SNPs leads to altered levels of inflammation and is associated with an increased risk of bone fractures,” the firm said.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.